Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
386
Total Claims
$19K
Drug Cost
86
Beneficiaries
$215
Cost/Patient
Risk Score Breakdown 39/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+614%
Opioid rate vs peers
44.8% vs 6.3% avg
-98%
Cost per patient vs peers
$215 vs $14K avg
-27%
Brand preference vs peers
10.6% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 614% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
44.8%
Opioid Rate
173
Opioid Claims
$14K
Opioid Cost
41.0%
Long-Acting Rate
This provider's opioid prescribing rate of 44.8% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 41 claims · $8,874
Generic: 345 claims · $9,639
Patient Profile
74
Avg Age
56%
Female
2.88
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About